Shukra Pharmaceuticals Ltd.
Snapshot View

60.20 -1.40 ▼-2.3%

05 August 2021, 04:00:00 P.M.
Volume: 142

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.shukrapharmaceuticals.com
Financial Indicators
Market Cap 9.61 Cr.
Earnings per share (EPS) 0.22 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 274.44 Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share 99.48 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.62 Calculated using Price: 61.35
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.16 Cr. 1,565,675 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-2.27%
1 Week
-4.67%
1 Month
-4.29%
3 Month
-35.96%
6 Month
+56.36%
1 Year
+71.75%
2 Year
+27.27%
5 Year
+12.31%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 95.75 -562.23 -11.39 0.94 0.85 3.51 3.55 3.04 0.23
Return on Capital Employed (%) 23.35 -26.76 -5.78 1.83 2.40 7.41 5.94 3.62 0.77
Return on Assets (%) 7.00 -19.87 -4.80 0.72 0.67 2.78 2.44 1.76 0.11

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1 0 14 14 14 15 15 15 15
Non Curr. Liab. 13 12 2 3 2 3 6 9 11
Curr. Liab. 2 2 2 1 1 2 3 4 7
Minority Int.
Equity & Liab. 16 14 18 18 17 19 24 28 34
Non Curr. Assets 2 10 11 11 11 12 16 17 19
Curr. Assets 14 3 7 7 6 7 8 11 14
Misc. Exp. not W/O
Total Assets 16 14 18 18 17 19 24 28 34

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 7 5 4 3 5 5 5 6 12
Other Income 0 0 0 1 0 0 0 0 0
Total Income 7 5 5 4 5 5 5 6 12
Total Expenditure -6 -5 -5 -3 -4 -4 -4 -4 -10
PBIDT 0 1 0 1 1 2 2 2 2
Interest 0 0 0 0 0
Depreciation 0 -1 -1 -1 0 0 -1 -1 -1
Taxation -1 0 0 0 -1 0 0 0
Exceptional Items 2 -3 0 -1 0
PAT 1 -3 -1 0 0 1 1 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. -7 10 -3 -2 3 0 1 0 1
Cash Fr. Inv. 2 -11 2 1 0 -1 -5 -2 -3
Cash Fr. Finan. 5 1 2 1 -1 3 2 2
Net Change 0 0 0 0 1 -1 0 0 0
Cash & Cash Eqvt 0 0 1 1 2 1 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 49.17 49.17 49.17 49.17 49.17 49.17 49.17 49.17 49.17
Public 50.83 50.83 50.83 50.83 50.83 50.83 50.83 50.83 50.83
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 21 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Dakshesh Shah
Designation :- Any Other
Wed, 21 Jul 2021
Shareholding for the Period Ended June 30 2021
Shukra Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Thu, 01 Jul 2021
Closure of Trading Window
Notice is hereby given that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and Companys code of conduct to Regulate Monitor and Report Trading by Designated Persons the trading window for the purpose of dealing in the securities of the Company closed from 01st July 2021 till 48 hours after the unaudited Financial results of the Company for the quarter ending on June 30 2021 are approved by the Board of Directors and filed with stock exchanges. The date of the Board meeting would be intimated in due course.

Accordingly all designated persons are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.

You are requested to take the same on record.

Thanking You.

Technical Scans View Details

Thu, 05 Aug 2021
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
20 SMA Crossing 50 SMA From Below 20 SMA Crossing 50 SMA From Below

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%